Join HSBC Innovation Banking as we kick off our 2025 Life Sciences & Healthtech Deal Day series. 

During this afternoon session we will be discussing some of the pertinent topics within Consumer Healthtech and delving deeper into some of the key trends we are seeing, such as: 

- November 2022, marquee venture investor a16z reports on "The Biggest Company in the World" saying, "We think the biggest company in the world will be a consumer health tech company" 

- According to our UK & Nordics: Life Sciences & Healthcare 2024 Venture Financing report: Alternative care (aka Consumer Healthtech) solutions led healthtech in first-financings, while 50% of the top UK & Nordics top financings were for Alternative Care models, with significant consumer interfaces; companies: Flo Health, Oura, Natural Cycles, Manual and Yazen 

- Building on this trend, grabbing headlines to start 2025, we see a scaling newcomer in Alternative Care: primary care model in Neko Health with a $260M Series B fundraise announcement 

- The consumer healthtech trend also rises with the tide of personalised health and medicine. The personalised medicine market has been valued at $529B in 2023, with an 8.2% CAGR 2024 - 2030.

We will also be joined by:

- Amber Vodegel, Exited Founder, CEO, NED, Investor

- Dr. Natalie Getreu, Founder & COO, Hertility

- Ross Harper, Founder & CEO, Limbic.AI

- Stuart Peak, CEO, HeliosX Group

as they join us to discuss their perspectives as Consumer Healthtech CEOs. The conversation will be moderated by our very own Dominick Kennerson, Director, HSBC Innovation Banking. 

To round off the afternoon Michael White, UK & Nordics Market Manager, HSBC Innovation Banking, will be joined by Tamara Orlova, CFO, Flo Health. 

RSVP to secure your place!